7.2% Kidmin intravenous solution Otsuka provides amino acids due to renal failure (200ml)

Dosage form Bottle x 200ml
Specifications L-Tyrosin, L-Aspartic Acid, L-glutamic Acid, L-Serine, L-Histidin, L-Proline, L-Threonin, L-Phenylalanine, L-Isoleucine, L-Valine, L-Alginin, L-L-leucin, L-lysin, L-Methihionine, L-Tryptophan, L-Trystiin
Ingredient OTSUKA Vietnam Pharmaceutical Joint Stock Company

Ingredient

Composition informationContent
L-Tyrosin0.1g
L-ASPARTIC Acid0.2g
L-Glutamic Acid0.2g
L-Serine0.6g
L-histidin0.7g
L-Proline0.6g
L-Threonin0.7g
L-phenylalanine1g
L-ISOLEUCINE1.8g
L-Valine2g
L-alanin0.5g
L-Arginin0.9g
L-leucin2.8g
L-lysin1.42g
L-Methionine0.6g
L-tryptophan0.5g
L-Cystein0.2g

Uses

Indications

Kidmin intravenous injection solution is indicated in the following cases:

  • Provide amino acids for patients with acute or chronic renal impairment in the following cases: Reducing blood protein; malnutrition; Before or after surgery. (Rats with kidney disease due to mercury chloride and rats removed the whole kidney):

    Increasing weight smoothly, nitrogen balance regularly.

    Normalization of blood amino and amino acid levels branched in muscle.

    Increase input 15N - Leucin into the blood protein segment.

    less nitrogen - urea in the blood.

    The effect of Kidmin provides amino acids studied on mice cutting 7/8 kidneys with a non -protein diet and the following nutritional effects are recorded:

    Improve nutritional status, proves by increased weight, nitrogen balance and normal blood amino.

    There is no nitrogen - urea hyperkemen.

    Dynamic pharmacokinetics

    When transmitting Kidmin to mark 14 carbon for 12 -week -old healthy mice and mouse cutting 7/8 kidneys with total venous nutrition, seeing a quick distribution of the body throughout the body, 50 - 90% merged into the protein segments of plasma, muscles and main organs such as the liver, kidney and spleen from 3 to 72 hours after transmission.

    The ratio of exhaled gases to exhale compared to the amount of marked substances transmitted in 32% in normal mice and 34% in the nephrotic cutting rats as up to 72 hours after transmission and the ratio of except for urine compared to the corresponding amount of quality transmitted substances is 4.6% and 4.9%.

  • Before taking 7.2% Kidmin intravenous solution Otsuka provides amino acids due to renal failure (200ml)

    How to use

    Kidmin uses intravenous infusion.

    Dosage

    Dosage for patients with chronic renal failure

    Communication through peripheral veins:

  • The usual dose for adults is 200 ml of solution/day. The normal communication speed for adults is 100 ml of solution for 60 minutes. Slow intravenous infusion in children, older people and serious patients. Fruit.
  • The total dosage of nutrition on the regular gastrointestinal tract in adults is 400 ml of Kidmin solution every day, dripping through the central vein system. Fruit.

    The total dosage of nutrition on the gastrointestinal tract in adults is 600 ml of Kidmin solution per day, drip transmission through the central venous system.

    Dosage is also adjusted depending on the weight, age and clinical condition of the patient.

    Should provide over 300 kcal energy without protein on 1 g of nitrogen (100 ml of this product) so that the use of amino acids effectively.

    Be careful:

    (1) Due to the symptoms of hyper ammonia blood or consciousness disorders reported to occur when using amino acid injections for patients with renal impairment as a single source of amino acids, it is necessary to stop using this product immediately when there are abnormal signs including slow reaction when being called or greeted, or a temporary focus on driving or expressing ideas.

    (2) Due to the symptoms of blood urea or metabolic acidic contamination may increase in case of inappropriate calories, patients should be closely monitored while taking the drug. If anything is abnormal, use appropriate measures such as stopping the drug.

    Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when overdose?

    Overdose

    The metabolites of amino acids can be retained, so it can deteriorate the patient's clinical condition.

    How to handle

    If there is an overdose, the patient's condition should be re -evaluated and applied appropriate treatments.

    What to do when forgetting 1 dose?

    Not applicable.

  • Side Effects

    When using Kidmin, you may experience unwanted effects (ADR).

    Reactions Unknown frequency
    0.1% - Chemistry AST (GOT), ALT (GPT), γ-AGP, ALP, LDH, Lap, or total bilirubin), hyper ammonia blood ammonia Quick Acid infection (ADR)

    Notify the doctor with unwanted effects when using the drug.

    Warnings

    Before using the drug you need to read the instructions carefully and refer to the information below.

    contraindicated

    Kidmin drug contraindicated in the following cases:

  • Patients with liver coma or risk of liver coma.

    Be cautious when using

    be cautious when using Kidmin in the following cases:

    Patients with cardiovascular disease.

    Patients with liver dysfunction or gastric hemorrhage.

    Patients with severe electrolyte balance disorders or acid - base balance.

    Used in older adults:

    Older patients often have impaired liver or cardiovascular functions, so it is necessary to closely monitor when used, reduce the dose by reducing the transmission speed.

    Use in children:

    Unknown safety when using kidmin in children (not enough clinical data).

    In children, the physiological system for metabolism of amino acids can develop incomplete. Therefore should be cautious when using Kidmin for children such as reducing the speed of transmission.

    Kidmin can cause hyperkalemia in mild infant. If there is an increased hemorrhage, the medication should be stopped, and the appropriate measures should be taken to reduce serum potassium.

    Note:

    Before opening a nylon bag, you need to check the color of the color indicator, do not use the bottle if the color indicator has turned blue or purple.

    Using only one -time bottle, in case of non -transmission, remove excess solution.

    Do not use bottles with fistula, cloudy or discolored holes

    Do not use expired bottles recorded on the label.

    The ability to drive and operate machinery

    should be cautious because the drug can reduce focus temporarily when driving or expressing ideas.

    Pregnancy

    Unknown safety when taking this drug for pregnant women. Therefore, this medication should only be used for pregnant women and women who are likely to be pregnant if the benefits are more likely to occur.

    Lactation period

    Unknown safety when taking this medication for pregnant women. Therefore, this medication should only be used for pregnant women and women who are likely to be pregnant if the benefits are more likely to occur.

    Interactive drug

    Interaction with other drugs: No data has been recorded.

    Cavalry: The physical and chemical properties of the drug solution may change (precipitate may appear) when combined with Kidmin with the following drugs:

    Sustainable drugs in alkaline environment.

    Water -soluble drugs.

    If these signs appear not to use drug solutions.

    To minimize the risk of a drug taboo when transmitting this drug with other drugs, check the turbidity and precipitate of the solution immediately after mixing the drug, before transmitting and checking periodically during the infusion process.

  • Storage

    Store in a cool dry place, the temperature does not exceed 30 ° C.

    To be out of reach of children.

    Other drugs

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    count views

    Popular Keywords